Neurogesx, Inc. (NGSX) Balance Sheet

Click line-items for a historical chart and %

Assets
Cash and cash equivalents	7.96M
Short-term investments	9.54M
Trade receivable	446K
Receivable from collaboration partner	67K
Inventories	53K
Prepaid expenses and other current assets	1.12M
Restricted cash	160K
Total current assets	19.35M
Property and equipment, net	264K
Other assets	343K
Restricted cash	50K
Total assets	20M
Liabilities and Stockholders' Deficit
Accounts payable	380K
Accrued compensation	933K
Accrued research and development	284K
Other accrued expenses	903K
Deferred product revenue, net	364K
Deferred collaboration revenue	7.24M
Long term obligations-current portion	8.4M
Total current liabilities	18.51M
Non-current liabilities:
Deferred collaboration revenue	19.68M
Deferred rent
Long term obligations	64.72M
Total non-current liabilities	84.57M
Commitments and contingencies	0
Stockholders' deficit:
Common stock	33K
Additional paid-in capital	243.43M
Accumulated other comprehensive gain (loss)	1K
Accumulated deficit	-326.53M
Total stockholders' deficit	-83.07M
Total liabilities and stockholders' equity (deficit)	20M

Entities mentioned with NGSX